Neurology News Network for the week ending January 24, 2025. [WATCH TIME: 4 minutes]
NeurologyLive® Staff
Advertisement
Articles by NeurologyLive® Staff
Neurology News Network for the week ending January 17, 2025. [WATCH TIME: 4 minutes]
Neurology News Network for the week ending January 10, 2025. [WATCH TIME: 4 minutes]
Neurology News Network for the week ending January 3, 2025. [WATCH TIME: 4 minutes]
As part of NeurologyLive®'s Year in Review 2025, we've compiled some of the top trending migraine trials.
NeurologyLive® provided in-depth coverage of conferences in 2025, highlighting advancements in diagnostics, treatments, and multidisciplinary care across multiple neurological conditions.
Discover key conversations from leaders in neurology covering a range of different clinically relevant topics.
Neurology News Network for the week ending December 27, 2025. [WATCH TIME: 4 minutes]
A look back at clinician-led features from 2025 that examine the questions, data, and decisions shaping neurologic care.
As part of NeurologyLive®'s Year in Review, take a look at our top expert interviews regarding multiple sclerosis in 2025.
As part of NeurologyLive®'s Year in Review, we've compiled some notable trials that began in 2025.
Neurology News Network for the week ending December 20, 2025. [WATCH TIME: 4 minutes]
Neurology News Network for the week ending December 13, 2025. [WATCH TIME: 4 minutes]
Neurology News Network for the week ending November 29, 2025. [WATCH TIME: 4 minutes]
Neurology News Network for the week ending November 22, 2025. [WATCH TIME: 4 minutes]
Neurology News Network for the week ending November 15, 2025. [WATCH TIME: 4 minutes]
Neflamapimod Phase 3 Trial in DLB, Troriluzole Gets CRL for SCA, Periodontal Disease and Stroke Risk
Neurology News Network for the week ending November 8, 2025. [WATCH TIME: 4 minutes]
Neurology News Network for the week ending November 1, 2025. [WATCH TIME: 3 minutes]
Neurology News Network for the week ending October 25, 2025. [WATCH TIME: 4 minutes]
Neurology News Network. for the week ending October 18, 2025. [WATCH TIME: 4 minutes]
Neurology News Network. for the week ending October 11, 2025. [WATCH TIME: 4 minutes]
Neurology News Network. for the week ending October 4, 2025. [WATCH TIME: 4 minutes]
Neurology News Network. for the week ending September 27, 2025. [WATCH TIME: 4 minutes]
Neurology News Network. for the week ending September 13, 2025. [WATCH TIME: 4 minutes]
Neurology News Network. for the week ending August 30, 2025. [WATCH TIME: 4 minutes]
Neurology News Network. for the week ending August 23, 2025. [WATCH TIME: 4 minutes]
Neurology News Network. for the week ending August 16, 2025. [WATCH TIME: 4 minutes]
Neurology News Network. for the week ending August 9, 2025. [WATCH TIME: 4 minutes]
Neurology News Network. for the week ending August 2, 2025. [WATCH TIME: 4 minutes]
Here's some of what is coming soon to NeurologyLive® this week.
Advertisement
Latest Updated Articles
NeurologyLive® Friday 5 — June 28, 2024Published: June 28th 2024 | Updated: July 2nd 2024
ND0612 Receives Complete Letter Response, Otsuka Terminates AVP-786, TSHA-102 Performs in Phase 1/2 REVEAL StudiesPublished: June 23rd 2024 | Updated: June 24th 2024
Abstracts for the 2024 CMSC Annual Meeting Are Now Live!Published: May 26th 2024 | Updated: May 28th 2024
The 2024 CMSC Annual Meeting Abstract GuidePublished: May 26th 2024 | Updated: May 28th 2024
Momentus Progress Within the MS Space Led by AHNPublished: November 1st 2021 | Updated:
New, Multisystem Insights Reveal Potential Treatment Pathways for Parkinson DiseasePublished: January 11th 2021 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Priority Review Granted for Weekly Subcutaneous Lecanemab Dosing in Early Alzheimer Disease
2
FDA Clears Pilavapadin for Phase 3 Development in Diabetic Peripheral Neuropathic Pain
3
Higher VMAT2 Target Occupancy Observed in Valbenazine Over Deutetrabenazine Extended-Release Capsules
4
Managing Postpartum MS: Safety Data, Relapse Risk, and Real-World Practice
5